<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">25628742</PMID>
      <DateCompleted>
        <Year>2015</Year>
        <Month>10</Month>
        <Day>26</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2020</Year>
        <Month>10</Month>
        <Day>01</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Print">1738-6586</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>11</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2015</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Journal of clinical neurology (Seoul, Korea)</Title>
          <ISOAbbreviation>J Clin Neurol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Paraneoplastic limbic encephalitis in a male with squamous cell carcinoma of the lung.</ArticleTitle>
        <Pagination>
          <StartPage>87</StartPage>
          <EndPage>91</EndPage>
          <MedlinePgn>87-91</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.3988/jcn.2015.11.1.87</ELocationID>
        <Abstract>
          <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Paraneoplastic limbic encephalitis (PLE) is a rare syndrome characterized by memory impairment, symptoms of hypothalamic dysfunction, and seizures. It commonly precedes the diagnosis of cancer. Small-cell lung cancer is the neoplasm that is most frequently reported as the etiology underlying PLE.</AbstractText>
          <AbstractText Label="CASE REPORT" NlmCategory="METHODS">This report describes a male patient who presented with neurologic symptoms consistent with anterograde amnesia, apathy, and disorientation. MRI revealed diffuse hyperintensities located predominantly in the medial bitemporal lobes, basal ganglia, frontal lobes, and leptomeninges on fluid attenuated inversion recovery images, suggesting PLE. Study of the primary tumor revealed squamous cell carcinoma of the lung. The patient was treated with neoadjuvant chemotherapy followed by surgery and adjuvant chemoradiotherapy, which resulted in his neurologic symptoms gradually improving.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">PLE might be a rare debut of squamous cell carcinoma of the lung. Treatment of the primary tumor may improve the neurologic symptoms.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Sauri</LastName>
            <ForeName>Tamara</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Catalan Institute of Oncology (ICO), Girona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Izquierdo</LastName>
            <ForeName>Àngel</ForeName>
            <Initials>À</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Catalan Institute of Oncology (ICO), Girona, Spain. ; Girona Biomedical Research Institute (IDIBGi), Girona, Spain. ; Cancer Registry of Girona, Girona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ramió-Torrentà</LastName>
            <ForeName>LLuis</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Girona Biomedical Research Institute (IDIBGi), Girona, Spain. ; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain. ; Department of Neurology, Dr. Josep Trueta University Hospital, Girona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sanchez-Montañez</LastName>
            <ForeName>Àngel</ForeName>
            <Initials>À</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Neuroradiology, Vall d'Hebron University Hospital, Barcelona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bosch-Barrera</LastName>
            <ForeName>Joaquim</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Catalan Institute of Oncology (ICO), Girona, Spain. ; Girona Biomedical Research Institute (IDIBGi), Girona, Spain. ; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Porta</LastName>
            <ForeName>Rut</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Medical Oncology, Catalan Institute of Oncology (ICO), Girona, Spain. ; Girona Biomedical Research Institute (IDIBGi), Girona, Spain. ; Department of Medical Sciences, School of Medicine, University of Girona, Girona, Spain.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2014</Year>
          <Month>11</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>J Clin Neurol</MedlineTA>
        <NlmUniqueID>101252374</NlmUniqueID>
        <ISSNLinking>1738-6586</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">limbic encephalitis</Keyword>
        <Keyword MajorTopicYN="N">lung cancer</Keyword>
        <Keyword MajorTopicYN="N">paraneoplastic syndrome</Keyword>
        <Keyword MajorTopicYN="N">squamous cell carcinoma</Keyword>
      </KeywordList>
      <CoiStatement>The authors have no financial conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2013</Year>
          <Month>7</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>5</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2014</Year>
          <Month>1</Month>
          <Day>8</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2015</Year>
          <Month>1</Month>
          <Day>30</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">25628742</ArticleId>
        <ArticleId IdType="pmc">PMC4302184</ArticleId>
        <ArticleId IdType="doi">10.3988/jcn.2015.11.1.87</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Graus F, Delattre JY, Antoine JC, Dalmau J, Giometto B, Grisold W, et al.  Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135–1140.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1739186</ArticleId>
            <ArticleId IdType="pubmed">15258215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78:381–385.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC2077770</ArticleId>
            <ArticleId IdType="pubmed">16980333</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dropcho EJ. Update on paraneoplastic syndromes. Curr Opin Neurol. 2005;18:331–336.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15891421</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dirr LY, Elster AD, Donofrio PD, Smith M. Evolution of brain MRI abnormalities in limbic encephalitis. Neurology. 1990;40:1304–1306.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2166250</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lawn ND, Westmoreland BF, Kiely MJ, Lennon VA, Vernino S. Clinical, magnetic resonance imaging, and electroencephalographic findings in paraneoplastic limbic encephalitis. Mayo Clin Proc. 2003;78:1363–1368.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14601695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brierley JB, Corsellis JA, Hierons R, Nevin S. Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain. 1960;83:357–368.</Citation>
        </Reference>
        <Reference>
          <Citation>Corsellis JA, Goldberg GJ, Norton AR. "Limbic encephalitis" and its association with carcinoma. Brain. 1968;91:481–496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">5723018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Burton GV, Bullard DE, Walther PJ, Burger PC. Paraneoplastic limbic encephalopathy with testicular carcinoma. A reversible neurologic syndrome. Cancer. 1988;62:2248–2251.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2460212</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dögel D, Beuing O, Koenigsmann M, Diete S. [Paraneoplastic limbic encephalitis resulting from non-Hodgkin-lymphoma: two case reports] Fortschr Neurol Psychiatr. 2008;76:41–46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">18189222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alamowitch S, Graus F, Uchuya M, Reñé R, Bescansa E, Delattre JY. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain. 1997;120(Pt 6):923–928.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">9217677</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajappa S, Digumarti R, Immaneni SR, Parage M. Primary renal lymphoma presenting with paraneoplastic limbic encephalitis. J Clin Oncol. 2007;25:3783–3785.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">17704429</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Howe MC, Chapman A, Kerr K, Dougal M, Anderson H, Hasleton PS. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy. Histopathology. 2005;46:195–201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15693892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dabbeche C, Guyon D, Loubes-Lacroix F, Manelfe C. [Paraneoplastic limbic encephalitis associated with epidermoid lung carcinoma] J Neuroradiol. 2005;32:278–280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16237368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voltz R. Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy. Lancet Neurol. 2002;1:294–305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12849427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gultekin SH, Rosenfeld MR, Voltz R, Eichen J, Posner JB, Dalmau J. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000;123(Pt 7):1481–1494.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">10869059</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schüller M, Jenne D, Voltz R. The human PNMA family: novel neuronal proteins implicated in paraneoplastic neurological disease. J Neuroimmunol. 2005;169:172–176.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16214224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med. 2003;349:1543–1554.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14561798</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
